cefuroxime has been researched along with Cancer of Prostate in 2 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martz, EW | 1 |
| Brewster, SF | 1 |
| MacGowan, AP | 1 |
| Gingell, JC | 1 |
1 trial available for cefuroxime and Cancer of Prostate
| Article | Year |
|---|---|
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.
Topics: Aged; Bacterial Infections; beta-Lactamases; Biopsy, Needle; Cefuroxime; Drug Therapy, Combination; | 1995 |
1 other study available for cefuroxime and Cancer of Prostate
| Article | Year |
|---|---|
Annual Scientific Program Summary. Medical Society of Delaware, Saturday, November 19, 1994.
Topics: Adult; Amoxicillin; Bone Diseases; Cefuroxime; Delaware; Doxycycline; Female; Humans; Lyme Disease; | 1995 |